ERBB2 and breast carcinoma: In breast cancer alone, for example, exogenous fatty acid uptake and oxidation have been shown to be increased in primary TNBC [92], following therapy resistance in Her2 breast cancer [18], and in residual disease across breast cancer subtypes [19].